Match Document Document Title
6054311 Recovering cryopreserved cells using gassed polyfluorinated compounds  
After the cryopreservation of living cells, the cells in a post-thaw recovery stage are supported by a gas permeable medium. This medium comprises at least one polyfluorinated compound. This...
6054298 Fringe proteins and pattern formation  
Isolated DNA encoding a protein or polypeptide having at least one biological activity of a vertebrate fringe protein, as well as the protein or polypeptide encoded thereby, are described. Assays...
6048713 Pseudomonas fluorescens  
A novel Pseudomonas fluorescens is disclosed which has an antagonist property against pathogenic fungi of the genera Pythium, Rhizoctonia, Sclerotinia and Gaeumannomyces and which has a DNA that...
6043088 Prostate/colon tumor suppressor gene located on human chromosome 8  
This invention provides a novel nucleic acid molecule encoding a prostate/colon tumor suppressor gene product. The means and methods for detecting mutations and/or loss of prostate/colon tumor...
6033897 Phytase-producing bacteria  
This invention relates to the isolation of thermophilic phytase-producing microorganisms, method for producing phytase using such microorganisms, phytase obtained therefrom, and usage of the...
6030625 Bordetella pertussis and Bordetella parapertussis strains  
An immunogenic composition, characterized in that it comprises an adenyl cyclase-hemolysin (Ac-Hly) protein, or an immunogenic portion of this AC-Hly, of a strain of Bordetella chosen from B....
6030609 Method and composition for treating paramyxovirus  
The present invention relates to a method of treating respiratory syncytial virus (RSV) through the exogenous administration of recombinant or natural interferon-beta (IFN-β) to lung epithelial...
6030811 Polynucleotides encoding a human mystrophin clone, HSABH01  
A human cDNA encoding human myotrophin and the polypeptide encoded thereby and a procedure for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for...
6027909 Bacillus strain and sporulation assay method  
6027888 Methods for producing soluble, biologically-active disulfide-bond containing eukaryotic proteins in bacterial cells  
Disclosed are methods of producing eukaryotic disulfide bond-containing polypeptides in bacterial hosts, and compositions resulting therefrom. Co-expression of a eukaryotic foldase and a disulfide...
6022728 Method for producing a bacterial vaccine and novel vaccines produced thereby  
A new method for the preparation of a whole cell bacterial vaccine for improved protection against bacterial pathogens, particularly against those pathogens which have multiple antigenic serotypes...
6022709 Nucleic acid encoding an altered telomere repeat binding factor  
The present invention provides an isolated altered vertebrate telomere repeat binding factor (A-TRF) that hinders the binding of a TRF to its specific telomere repeat sequence. Also included are...
6022711 Human growth hormone variants having enhanced affinity for human growth hormone receptor at site 1  
Growth hormone participates in the regulation of normal growth and development processes. The binding affinity of growth hormone for its target receptors is dependent upon the interaction of site 1...
6022741 Regulatory genetic DNA that regulates the Class II transactivator (CIITA)  
Novel DNAs that regulate expression of the Class II Transactivator (CIITA) gene are disclosed. Recombinant DNA comprising CIITA regulatory elements operably associated with a heterologous DNA are...
6022828 Xanthomonas campestris as biological control of Poa trivialis  
A method for controlling Poa trivialis using a bacterium which is a Xanthomonas campestris pathovar which produces a wilt in the weed grass is described. In particular, the use of a Xanthomonas...
6022727 Method for forming reversible colloidal gas or liquid aphrons and compositions produced  
A method for forming gas or liquid aphrons with reversible surfactants or emulsifiers is described. Polymers which change their emulsifying properties upon change of pH, temperature or other...
6020194 DNA encoding a Myt1 polypeptide  
The present invention provides a threonine/tyrosine kinase, Myt1, that phosphorylates the cyclin-dependent kinase, Cdc2, to provide regulation of the cell cycle at the G2/M interphase. Also...
6020160 RsbV-1 polynucleotides of Staphylococcus aureus  
RsbV-1 polypeptides and DNA (RNA) encoding such RsbV-1 and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such RsbV-1...
6019984 Bacterial preparations, method for producing same, and their use as vaccines  
Novel bacterial preparations containing one or more isolated and purified strain of a microorganism which produces one or more RTX toxins, and which strain has at least one RTX toxin which is...
6017748 Cloning host organisms  
Methods and materials for the cloning of DNA, in particular, for the cloning of "unclonable" DNA using genetically engineered host cells. Host cell organisms have been discovered that stabilize and...
6017758 DMNPE caged nucleic acid and vector  
The present invention provides an isolated nucleic acid covalently linked to a photolabile caging group which reversibly prevents expression of the nucleic acid. The present invention further...
6013468 RNA component of telomerase  
Nucleic acids comprising the RNA component of a mammalian telomerase are useful as pharmaceutical, therapeutic, and diagnostic reagents.
6010896 Lyophilized ionizing radiation sterilized microorganisms as an additive for nutrient media for growing bacteria  
A media additive for the promotion of the growth of anaerobic and aerobic bacteria is presented. The additive comprises lyophilized microorganisms exposed to ionizing radiation. The microorganisms...
6011146 Altered major histocompatibility complex (MHC) determinant and methods of using the determinant  
An altered MHC class I determinant comprises α 1 , α 2 , α 3 , β 2 -microglobulin (β 2 m) polypeptide domains encoded by a mammalian MHC class I locus in which the α 3 domain is covalently...
6008010 Method and apparatus for holding cells  
The present invention pertains to an apparatus for holding cells. The apparatus comprises a mechanism for incubating cells having a dynamically controlled closed environment in which the cells are...
6008040 Procedures for efficient separation of cells, cellular materials and proteins  
A process and device are provided for achieving cascade flow to achieve rapid separations of target components from fluid mixtures is provided. The devices of the invention have a cascading flow...
6004805 Transcriptional enhancer from milk protein genes  
The invention relates to novel enhancer nucleotide sequences which stimulate transcription of heterologous DNA in cells in culture. The enhancers are derived from major milk protein genes by the...
6001585 Micro hollow fiber bioreactor  
A "micro" hollow fiber bioreactor and method of use are provided for use in screening different cell lines and process conditions. The bioreactor includes the use of an oxygen permeable (e.g.,...
5997881 Method of making non-pyrogenic lipopolysaccharide or A  
The present invention provides gram-negative bacterial strains that produce substantially pure non-pyrogenic lipopolysaccharide or lipid A. The present invention also relates to a use of said...
5998170 Polynucleotides encoding hepatocyte-specific members of the FGF family  
Nucleic acid molecules are described which are useful in vectors, transformed or transfected host cells, and methods for the recombinant expression of hepatocyte growth-specific polypeptide members...
5989862 Tab1 protein and DNA coding therefor  
TAB1 protein having activity which activates factor TAK1 in the TGF-β signaling pathway, and having the amino acid sequence shown in FIG. 1.
5989848 Use of human immortalized endothelial cells to isolate and propagate Ehrlichia chaffeensis and Ehrlichia canis  
This invention provides a purified immortalized human endothelial cell infected with Ehrlichia chaffeensis or Ehrlichia canis. Also provided is a method of simultaneously screening a sample from a...
5985620 TNF-α Ribozymes  
This invention describes compounds active against TNF-α mRNA. It further describes RNA molecules capable of conferring stability to RNA in vivo through an endogenous ribozyme binding protein(s)....
5985286 Bordetella strains  
The invention relates to an immunogenic composition, characterized in that it comprises an adenyl cyclase-hemolysin (AC-Hly) protein, or an immunogenic portion of this AC-Hly, of a strain of...
5981260 Process for the production of cell mass and/or fermentation products under sterile conditions  
Process for the production of cell mass and/or fermentation products under sterile conditions, during which the fermentation mixture, at least at times, is recycled and the metabolic products of...
5981274 Recombinant hepatitis virus vectors  
The present invention relates to recombinant hepatitis viral vectors useful for the expression of functional heterologous gene products in liver cells. It is contemplated that these vectors will...
5976833 Method for animal cell culture  
The object of the present invention is to provide a method for improving productivity in the production of useful substances by animal cells. The present invention discloses a method for animal...
5972643 Isolated polynucleotide molecules encoding CTCF, a CCCTC-binding factor  
Polynucleotide molecules encoding CTCF are isolated and purified and sequenced. The CTCF proteins and antibodies thereto can be used to identify mutant CTCFs in methods of diagnosis.
5968807 Culture media containing glycerol that are pH and color stable when heat sterilized  
A heat stable culture medium is prepared by substituting glycerol for carbohydrate components such as dextrose that are prone to Maillard reactions. A preferred medium contains pancreatic digest of...
5968525 Inactivated Mycolplasma hyopneumoniae and uses therefor  
The invention relates to a method for making an inactivated vaccine of Mycoplasma hyopneumoniae by inactivating the bacteria with Thimerosal. The resulting bacterin is mixed with an adjuvant of...
5968771 Global ischemia induced gene  
The nucleotide sequence is provided for a novel death regulatory gene. In particular the present invention relates to a DNA segment encoding a giig15b gene; polypeptides encoded by that DNA...
5968738 Two-reporter FACS analysis of mammalian cells using green fluorescent proteins  
Two spectrally distinguishable GFPs are used as reporters in mammalian cells to simultaneously and independently analyze the expressions of two transcriptional elements. The two GFPs, encoded by...
5965396 Human lymph node derived GTPase  
A novel human GTPase polypeptide intracellular molecular switch is described. A full length cDNA which encodes the signal transduction polypeptide is disclosed as well as the interior structural...
5965422 Lysophospholipase produced from aspergillus by recombinant methods  
This invention relates to a recombinant deoxyribonucleic acid (DNA) isolatable from Aspergillus, preferably Aspergillus foetidus, wherein it codes for a lysophospholipase (LPL) and has the...
5962267 Proinsulin derivative and process for producing human insulin  
A process for preparing human insulin, which comprises the steps of: preparing a DNA encoding a human proinsulin derivative having the following formula (I); inserting the DNA into a vector to...
5962314 Calcium receptor-active molecules  
The present invention relates to the different roles inorganic ion receptors have in cellular and body processes. The present invention features: (1) molecules which can modulate one or more...
5958754 Secretion of insulin-like growth factor-I in E. coli  
A method for bacterially producing IGF-I is disclosed in which Gram-negative bacteria are caused to express a gene consisting of a lamB or ompF signal sequence operatively joined to a DNA sequence...
5958735 Polynucleotides encoding urogenital sinus derived growth inhibitory factor and vectors  
Urogenital sinus derived growth inhibitory factor is a protein having growth-inhibitory and antiprotease properties. The present invention relates to amino acid and nucleotide sequences for...
5958414 Composition to protect a mammal against Bartonella henselae infection  
The present invention relates to a therapeutic composition to protect a mammal from B. henselae infection that includes an isolated B. henselae antigen and an adjuvant comprising a phosphazene...
5958697 Isolated nucleic acids encoding CYP7 promoter-binding factors  
The invention provides methods and compositions relating to CPF proteins which regulate transcriptional activation, and related nucleic acids. The polypeptides may be produced recombinantly from...